Responses
Scientific Abstracts
Rheumatoid arthritis - other biologictreatment
SAT0105 Summacta: A Randomized, Double-Blind, Parallel Group Study of the Safety and Efficacy Of Tocilizumab SC Versus Tocilizumab IV, in Combination with Traditional Dmards in Patients With Moderate to Severe Ra
Compose a Response to This Article
Other responses
No responses have been published for this article.